Cargando…

Intravesical recurrence of chromophobe renal cell carcinoma

Metachronous metastasis from renal cell cancer (RCC) after radical surgery can occur in up to one third of patients, most commonly from clear cell RCC. Metastatectomy is a suitable management strategy in oligometastatic disease. We present the case of a 78-year-old woman who developed haematuria 2 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Niall P., McLornan, Liza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338959/
https://www.ncbi.nlm.nih.gov/pubmed/37455772
http://dx.doi.org/10.1016/j.eucr.2023.102479
_version_ 1785071744411762688
author Kelly, Niall P.
McLornan, Liza
author_facet Kelly, Niall P.
McLornan, Liza
author_sort Kelly, Niall P.
collection PubMed
description Metachronous metastasis from renal cell cancer (RCC) after radical surgery can occur in up to one third of patients, most commonly from clear cell RCC. Metastatectomy is a suitable management strategy in oligometastatic disease. We present the case of a 78-year-old woman who developed haematuria 2 years after left radical nephroureterectomy for a pT3aNx chromophobe RCC (ChRCC). No adjuvant therapy was given and surveillance to date was negative for metastasis. A large solitary bladder tumour which was resected, and histopathology confirmed intravesical recurrence of the ChRCC. We present this case and discuss intravesical recurrences of renal cancer.
format Online
Article
Text
id pubmed-10338959
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103389592023-07-14 Intravesical recurrence of chromophobe renal cell carcinoma Kelly, Niall P. McLornan, Liza Urol Case Rep Oncology Metachronous metastasis from renal cell cancer (RCC) after radical surgery can occur in up to one third of patients, most commonly from clear cell RCC. Metastatectomy is a suitable management strategy in oligometastatic disease. We present the case of a 78-year-old woman who developed haematuria 2 years after left radical nephroureterectomy for a pT3aNx chromophobe RCC (ChRCC). No adjuvant therapy was given and surveillance to date was negative for metastasis. A large solitary bladder tumour which was resected, and histopathology confirmed intravesical recurrence of the ChRCC. We present this case and discuss intravesical recurrences of renal cancer. Elsevier 2023-06-29 /pmc/articles/PMC10338959/ /pubmed/37455772 http://dx.doi.org/10.1016/j.eucr.2023.102479 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Oncology
Kelly, Niall P.
McLornan, Liza
Intravesical recurrence of chromophobe renal cell carcinoma
title Intravesical recurrence of chromophobe renal cell carcinoma
title_full Intravesical recurrence of chromophobe renal cell carcinoma
title_fullStr Intravesical recurrence of chromophobe renal cell carcinoma
title_full_unstemmed Intravesical recurrence of chromophobe renal cell carcinoma
title_short Intravesical recurrence of chromophobe renal cell carcinoma
title_sort intravesical recurrence of chromophobe renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338959/
https://www.ncbi.nlm.nih.gov/pubmed/37455772
http://dx.doi.org/10.1016/j.eucr.2023.102479
work_keys_str_mv AT kellyniallp intravesicalrecurrenceofchromophoberenalcellcarcinoma
AT mclornanliza intravesicalrecurrenceofchromophoberenalcellcarcinoma